China National Medicines Corporation Ltd. (SHA: 600511)

Market Cap	25.82B
Revenue (ttm)	51.19B
Net Income (ttm)	2.16B
Shares Out	754.50M
EPS (ttm)	2.87
PE Ratio	11.93
Forward PE	10.71
Dividend	0.85 (2.50%)
Ex-Dividend Date	n/a

Volume	4,278,931
Open	34.63
Previous Close	34.73
Day's Range	34.00 - 34.93
52-Week Range	27.12 - 38.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About China National Medicines Corporation

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,138
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2023, China National Medicines Corporation's revenue was 49.70 billion, an increase of 9.23% compared to the previous year's 45.50 billion. Earnings were 2.15 billion, an increase of 9.26%.